Let's focus on what we can do!

By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • Fingolimod in multiple sclerosis: No hint of added benefit in new therapeutic indication – EurekAlert (press release)

Fingolimod in multiple sclerosis: No hint of added benefit in new therapeutic indication – EurekAlert (press release)

Monday, 14 March, 2016

Fingolimod in multiple sclerosis: No hint of added benefit in new therapeutic indication – EurekAlert (press release)

Since its approval in 2011, the multiple sclerosis drug fingolimod (Gilenya) has already undergone three early benefit assessments, all of which were mainly based on the approval study TRANSFORMS. After a new modification of the therapeutic indication ...

Read More

Source:Fingolimod in multiple sclerosis: No hint of added benefit in new therapeutic indication - EurekAlert (press release)

Categories :
  • Latest Headlines
  • Multiple Sclerosis
  • Uncategorized
Socials :

Recent posts